Form 8-K - Current report:
SEC Accession No. 0001104659-25-029612
Filing Date
2025-03-31
Accepted
2025-03-31 07:15:39
Documents
15
Period of Report
2025-03-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2510876d1_8k.htm   iXBRL 8-K 24101
2 EXHIBIT 99.1 tm2510876d1_ex99-1.htm EX-99.1 11914
3 GRAPHIC tm2510876d1_ex99-1img001.jpg GRAPHIC 27033
  Complete submission text file 0001104659-25-029612.txt   250704

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tela-20250331.xsd EX-101.SCH 3012
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tela-20250331_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tela-20250331_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2510876d1_8k_htm.xml XML 3681
Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Filer) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39130 | Film No.: 25788876
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)